(Q73701966)
Statements
Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma (English)
Isaac Ben-Bassat
Izhar Hardan
Arnon Nagler
Avichai Shimoni
Abraham Avigdor
Moshe Yeshurun